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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not 
curcuminoids are effective in reducing knee pain in adults with knee osteoarthritis. 
 
STUDY DESIGN: A review of two English language double-blind placebo-controlled 
randomized controlled trials and one double-blind randomized control trial (RCT) published 
within peer-reviewed journals after the year 2013. The studies include adult participants age 40 
and over. 
 
DATA SOURCES: Double-blind randomized controlled trials were found using PubMed 
database. These studies compared treatment with curcuminoids with ibuprofen or a placebo. 
 
OUTCOMES MEASURED: Clinical outcomes of pain, stiffness and function were measured 
using the traditional Western Ontario & McMaster Universities Arthritis Index (WOMAC) and 
Visual Analog Scale (VAS); 6-minute walk distance to measure function; use of adjunctive non-
steroidal anti-inflammatory drugs (NSAIDs) for pain management. This review will primarily 
focus on the areas of pain outcome. 
 
RESULTS: One RCT found that curcuminoids provided a significant drop from baseline pain 
after 4 weeks using the Thai modified WOMAC scale, and showed a better safety profile versus 
ibuprofen.  Two RCTs found that curcuminoids provided a significant decrease in baseline as 
well as a greater decrease in pain outcomes when compared to that of the placebo control group 
measured using the traditional WOMAC scale and VAS after 6 and 8 weeks, respectively.  It is 
also worth noting that both of these RCTs also showed significant reduction in patient use of 
NSAIDs as an adjunctive in pain management when compared to the placebo group. 
 
CONCLUSION: The results of the three randomized controlled trials present evidence that 
curcuminoids, given short-term, can effectively reduce knee pain in adults with knee 
osteoarthritis and coincidentally decrease the dependence on NSAIDs as adjunctive pain 
management. Curcuminoid dosages and dosing schedules, duration of therapy, and safety of 
treatment need to be more accurately determined through future trials. 
 
KEY WORDS: curcumin, curcuma domestica, knee osteoarthritis, therapy 
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INTRODUCTION 
 Osteoarthritis (OA) is the most common form of arthritis and is the leading cause of 
disability in adults, effecting over 30 million adults in the United States.5   Osteoarthritis is a 
progressive disease of the entire joint most commonly affecting adults age 40 and above, but can 
severely hinder quality of life at any age.5  Osteoarthritis accounts for more than twenty-five 
percent of all arthritis related health care visits, contributing to more than 27 billion dollars in 
health care expenditures annually.1  According to the Arthritis Foundation, in 2012 over one 
million total joint arthroplasties were performed at a cost of 18.8 billion dollars.1  In addition to 
extensive healthcare costs, earning losses due to osteoarthritis cost an estimated 80 billion dollars 
per year between 2008 and 2011.1  There is currently no cure available for osteoarthritis, and 
treatment methods have continually plateaued over the last decade. This paper evaluates three 
double-blind randomized controlled trials (RCTs) comparing the efficacy of curcuminoids in 
reducing knee pain in patients with knee osteoarthritis when used as an oral therapeutic agent. 
Osteoarthritis is a progressive disease of one or multiple joints, characterized by the 
breakdown of cartilage, bony changes in the joints, deterioration of the tendons and ligaments, 
and various degrees of inflammation of the joint lining.5  Most commonly, osteoarthritis occurs 
in the hand joints, spine, and weight bearing joints such as the hips, knees, and great toes.5 
Symptoms of osteoarthritis include joint pain and stiffness, knobby swelling of the joint, 
cracking or grinding noise with movement, and decreased joint function.5 Diagnosis of 
osteoarthritis is primarily a clinical diagnosis based on a complete history and physical, and may 
include joint imaging using X-ray or higher level technology.5  Risk factors for osteoarthritis 
include a positive family history, repetitive use or overuse of joints, and joint deformity.5  An 
individual’s risk of developing osteoarthritis significantly increases with obesity, traumatic joint 
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injury, and increasing age.5  The lifetime risk of knee and hip osteoarthritis are 46% and 25%, 
respectively.5   
Traditionally, treatment methods begin with the most conservative options and follow a 
stepwise progression as needed.  Because there is no cure for osteoarthritis, the goal of treatment 
is to manage pain and improve functionality.5 Symptoms appear to be best controlled when 
focusing on the anti-inflammatory processes, including cyclooxygenase (COX) and other 
enzymes.5  Most commonly, patients suffering from osteoarthritis will be encouraged to increase 
physical activity and lose weight.5 Current standard of care for osteoarthritis patients mainly 
relies on the use of non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics.3 If 
symptoms persist, physical therapy, prescription pain medication, and/or periodic joint injections 
may be pursued.5  As the disease progresses and becomes increasingly debilitating patients may 
begin to use supportive devices and the most invasive option, joint surgery or replacement, may 
be explored at this time.5   
Rather than continue to depend on NSAIDs and prescription pain medications, patients 
are turning to more natural sources and alternative medicines to manage their osteoarthritis pain.  
Recently, the supplement known as Turmeric, a curcuminoid, has been called into question as an 
anti-inflammatory agent.2,3,6 Curcuminoids are a classification of medication that use a pigment 
isolated from the plant Curcuma longa, more commonly known as turmeric.4  Curcuminoids 
possess anti-inflammatory properties as a result of the inhibition of enzymes involved in 
inflammation, such as COX;4 they also disrupt cell signal transduction by various mechanisms, 
including inhibition of protein kinase C.4 Due to the pharmacotherapeutics and safety profile of 
curcuminoids, this class of medication has been shown to be effective in reducing knee pain in 
adults with knee osteoarthritis.2,3,6  
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OBJECTIVE 
The objective in this systematic review is to determine whether or not curcuminoids are 
effective in reducing knee pain in adults with knee osteoarthritis (OA).  
METHODS 
 All three studies selected for this systematic review included randomized controlled trials 
evaluating primary knee osteoarthritis patients over the age of 40 with no contraindications to 
curcuminoid therapy (see Table 1).  Each study included a randomized group that received oral 
curcuminoid therapy compared to a control group, which received an oral placebo and/or a non-
steroidal anti-inflammatory drug (NSAID).  Outcomes measured in each study include knee pain, 
stiffness, and function.  This systemic review will focus on knee pain. 
 Slight variations in each of the studies did exist, including age groups, curcuminoid 
product and dosage, duration of therapy, and scales used to measure outcomes (see Table 1).  
The study conducted by Kuptniratsaikul et al. compared the change in baseline between patients 
older than 50 years old receiving ibuprofen (control group) and patients receiving curcuma 
domestica for 4 weeks using a modified WOMAC scale (1200mg and 1500mg per day, 
respectively).2 The study conducted by Nakagawa et al. compared the change in baseline 
between patients older than 40 years old receiving 1080 mg of Theracumin, a curcuminoid, per 
day and a control group receiving a placebo at two, four, six and eight weeks using the Visual 
Analog Scale (VAS).3 The study completed by Panahi et al. focused on an older age group, older 
than 80 years old, comparing a placebo group with a group that received 1500mg of curcuminoid 
product per day for 6 weeks using both the traditional WOMAC scale and VAS.6 Additional 
inter-study differences are mentioned in Table 1 and elsewhere in this review. 
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 Articles for this review were found using the search engine on the PubMed database, 
using the key words “curcumin, knee osteoarthritis, therapy” and “curcuma domestica.”  The 
search was further filtered by only including papers published in peer-reviewed journals in the 
English language within the past 10 years.  From this search, articles were selected based on their 
relevance to the objective, and if the studies included outcomes that focus on patient-oriented 
evidence that matters (POEMs). The specified search criteria excluded studies not published 
within the past 10 years, studies that did not include pain and functionality outcome 
measurements, and patients under the age of 40 years old. All three selected studies contain non-
dichotomous data, and statistics evaluated in each study include p-values, confidence intervals 
(CI), and change in mean from baseline. 
Table 1 – Demographics of Selected Studies 
Study  Type # 
Pts 
Age 
(yrs) 
Inclusion Criteria Exclusion Criteria W
/D 
Interventions 
Kuptniratsa
ikul2 
Double- 
blind RCT 
367 > 50 Primary knee OA per 
the ARA criteria with 
numerical rating of 
knee pain greater than 
or equal to 5/10, age 
greater than or equal to 
50 years old 
Abnormal liver or 
renal function, 
history of PUD, 
allergy to curcumin 
or ibuprofen, unable 
to walk 
36 Ibuprofen 
1200mg qd x 
4 weeks  
 
VS  
 
Curcuma 
domestica 
extracts 
1500mg QD 
x 4 weeks 
Nakagawa3 Double-
blind 
placebo-
controlled 
RCT 
50 > 40 Primary medial knee 
OA, age > 40, kellgren-
lawrence grades II or 
III 
History of knee 
surgery, injection 
treatment during 
study, knee steroid 
injection treatment 
within 2 months of 
study, steroids within 
4 weeks of study 
9 Theracurmin 
180mg QD x 
8 weeks 
 
VS 
 
Placebo QD 
x 8 weeks 
Panahi6 Double-
blind 
placebo-
controlled 
RCT 
53 > 80 Degenerative primary 
knee OA with mild to 
moderate severity, 
bilateral OA, age > 80, 
diagnosis based on 
criteria defined by ACR 
Curcuminoid allergy, 
joint replacement, 
malabsorption 
disorders, heart 
failure, liver failure, 
renal failure, 
corticosteroid use, 
joint injections w/i 3 
mo, hx of psych d/o 
13 Curcuminoid 
1500mg QD 
x 6 weeks 
 
VS 
 
Placebo QD  
x 6 weeks 
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OUTCOMES MEASURED 
 All outcomes measured were those of patient-oriented evidence that matters (POEMs). 
The outcomes measured in the selected studies were knee pain, stiffness, and function.  One 
study used the 6-minute walk distance and a modified Thai version of the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC), a health status questionnaire asking 
patients to measure symptoms on a scale of 0-10, with higher scores representing increased pain, 
at baseline and 4 weeks.2 One study measured outcomes on the Visual Analog Scale (VAS), a 
continuum used to measure intensity or frequency of symptoms, at baseline, two, four, six, and 
eight weeks.3 One selected study measured outcomes using both the traditional WOMAC, on a 
scale of 0-4, and VAS at baseline and six weeks.6 
RESULTS 
This selective systematic review contains three studies of randomized controlled trials 
evaluating the efficacy of curcuminoids in knee osteoarthritis pain. All three studies follow a per-
protocol analysis. Two of the selected studies compare curcuminoid oral therapy to a placebo 
group, while one study compares the effectiveness of curcuminoids to that of ibuprofen (see 
Table 1).  All three selected studies contain non-dichotomous data, and statistics evaluated in 
each study include p-values, confidence intervals (CI), and change in mean from baseline. 
Variations in each study are discussed elsewhere, including differing interventions and length of 
time. 
The 2014 study by Kuptniratsaikul et al. evaluated the efficacy and safety of curcuminoid 
extracts versus that of ibuprofen, a currently accepted treatment for osteoarthritis, by measuring 
WOMAC scores in 367 patients at baseline and four weeks.2 See Table 1 for the interventions 
carried out in this study. The compliance rate of both treatment groups in this study was greater 
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than 90%.2 The trial found that the baseline WOMAC pain score of 5.3 +/- 1.8 was nearly cut in 
half after four weeks of treatment with curcuminoid extracts, with a four week WOMAC pain 
score of 3.25 +/- 2.11.2 The estimate of the treatment effect is accurate, demonstrated by a 
confidence interval (CI) of 95% and a p-value of 0.018.2 Ultimately, this study concluded that 
curcuminoid extracts are equally effective to ibuprofen in pain reduction for patients suffering 
with knee osteoarthritis.2 Table 2 shows the WOMAC pain scores at different intervals for each 
of the respective groups. Not shown in the table includes the total WOMAC score, stiffness and 
function subscales of the WOMAC score, and the 6-minute walk distance, since this selective 
review is focusing only on knee pain.  In addition, the study also found that curcuminoid extracts 
have a better safety profile, as more patients were lost in the ibuprofen group due to 
gastrointestinal adverse effects (n=7) than compared to the curcuminoid treatment group (n=1).2  
Table 2 – Curcuminoids vs Ibuprofen (Kuptniratsaikul et al. 2014)2 
 Baseline 
WOMAC pain 
4-week 
WOMAC pain 
Confidence 
Interval (CI) 
P-Value 
Ibuprofen 
(n=160) 
5.2 +/- 1/7 3.17 +/- 1.98  
95% 
 
0.018 
C. Domestica 
(n=171) 
5.3 +/- 1.8 3.25 +/- 2.11 
 
 The 2014 study by Panahi et al. compared curcuminoid treatment in 40 knee 
osteoarthritis patients compared to a placebo group using traditional WOMAC and VAS scores 
at baseline and six weeks.6 There was no significant difference in age, gender, body mass index, 
and VAS and WOMAC scores between the study groups at baseline (P>0.05).6 The treatment 
group received 1500mg of curcuminoid per day, while the alternative group received a placebo 
daily for 6 weeks.  Treatment with curcuminoids was associated with significantly greater 
reductions in WOMAC scores (p=0.001) and VAS scores (p <0.001) compared with the placebo 
group scores.6 When comparing specific WOMAC subscales, there were significant 
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improvements in pain and physical function scores, however, there was no significant change in 
stiffness score.6  
Pain scores can be seen below in Table 3.  In addition to the pain score improvements, this study 
found that the proportion of subjects whose use of naproxen (NSAID) was reduced by the end of 
the trial was significantly higher in the curcuminoid group (84%) versus the placebo group 
(19%).6 No considerable adverse effects were noted in this study. 
Table 3 – Curcuminoids vs Placebo (Panahi et al. 2014)6 
 Group Before Treatment After Treatment P-value 
WOMAC overall Curcuminoids 42.4 +/- 18.3 25.0 +/- 13.0 <0.001 
 Placebo 44.6 +/- 17.3 40.6 +/- 12.6 0.072 
WOMAC pain Curcuminoids 9.9 +/- 4.1 6.1 +/- 2.9 <0.001 
 Placebo 10.5 +/- 4.0 9.4 +/- 3.4 0.025 
VAS score Curcuminoids 66 36 <0.001 
 Placebo 30 58 >0.05 
 
 The 2014 study by Nakagawa et al. also compares the short-term effects of curcuminoid 
therapy as compared to a placebo group at baseline, two, four, six, and eight weeks.3 Patients 
randomly assigned to the treatment group received 180mg of Theracurmin, a research developed 
surface-controlled dispersible curcumin product, per day for eight weeks.3 Knee pain VAS scores 
were significantly lower in the Theracurmin group than in the placebo group, with the exception 
of the six patients with initial VAS scores of equal to or below 0.15.3 The average baseline VAS 
score in the placebo group was 0.42, and after eight weeks dropped to 0.21.3 The mean VAS in 
the Theracurmin group at baseline and eight weeks were 0.52 and 0.20, respectively, with a p-
value of 0.023.3 Additionally, this study found that Theracurmin lowered the celecoxib (NSAID) 
dependence significantly when compared to the placebo group.3 No considerable adverse effects 
were mentioned in this study.  Data from this study can be found below in Table 4. 
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Table 4: Theracurmin vs Placebo (Nakagawa et al. 2014)3 
 Theracurmin Placebo 
Baseline VAS score 0.52 0.42 
8-week VAS score 0.20 0.21 
Baseline Celecoxib use (%) 72 83 
8-week Celexicob use (%) 32 61 
  
DISCUSSION 
 While all three studies showed a significant change in baseline in adult osteoarthritis knee 
patients, there were certain limitations in each study that need to be taken into consideration. All 
three selected studies evaluated short-term effectiveness of curcuminoids, measuring final 
outcomes at four, six, and eight weeks respectively.  Both the Panahi et al. and the Nakagawa et 
al. studies had significantly smaller patient populations, including only 53 and 50 patients.3,6 
These population sizes are large enough to have significance in the given studies, however, 
larger-scaled studies should be performed in the future to see if these results can be replicated. 
The 2014 study conducted by Panahi et al. was completed in patients older than 80 years 
old, which is typically classified as a different age group rather than “adult.”6 This jump in age 
classification may be considered as an outlier in this selective review.  Although all patients are 
accounted for, this study had the largest loss of follow-up (24.53%) due to patients dropping out 
or becoming involved in an alternative therapy that then eliminated the individual from the 
study, as stated by the exclusion criteria.6 
In order to best evaluate the effects of curcuminoids, two of the selected studies gave oral 
medications that had altered pharmacokinetics in order to enhance the absorption of the given 
curcuminoid.  The 2014 Nakagawa study provided patients in the treatment group with 
Theracurmin, a curcuminoid product that was created by researchers to enhance absorption.3 In 
addition, the Panahai et al. study specifies that the curcuminoid oral medication was 
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administered with Biperine to enhance absorption of the medication, which may have a direct 
effect on the outcomes evaluated in the study.6  
The 2014 study completed by Kuptniratsaikul et al. is the only study that mentions 
adverse effects of the curcuminoid product.  This study does not go into detail regarding the 
specifics of the adverse event, however, there was one patient in the curcuminoid treatment 
group that dropped out of the trial due to gastrointestinal (GI) adverse effects.2 The only other 
mention of adverse effects comes from the 2014 Nakagawa study, where it is stated that 
curcuminoids can actually be protective of the gastric mucosa, as compared to the damaging 
adverse effects with non-steroidal anti-inflammatory drugs.3 The only clearly stated 
contraindication to curcuminoids is in patients with a curcuminoid allergy.2,6 Future studies 
should focus on the side effect profile of curcuminoids in order to paint a more complete picture. 
 The accessibility of curcuminoids as knee osteoarthritis therapy cannot be ignored when 
discussing the effectiveness of treatment.  Currently, no curcuminoid product is approved or 
endorsed by the Food and Drug Administration (FDA) for any specific disease treatment.  In 
addition to current studies evaluating curcuminoid effectiveness in treating osteoarthritis, there 
are studies being conducted surrounding the role of curcuminoids in gastrointestinal and cardiac 
diseases, some cancers, and other inflammatory conditions.2,3,6 Access to curcuminoid products 
parallels the vitamin industry, with availability at almost any drug store, grocery store, and 
nutrition shop.  Curcuminoids are typically available in these location as Turmeric powder, oral 
pill form, or as oral combination products.  If curcuminoids become a FDA approved treatment, 
the current ease of access may become more difficult as the medication(s) will become regulated.  
The question remains whether or not insurance will cover curcuminoid products if they become 
an approved FDA treatment for osteoarthritis.   
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CONCLUSION 
Curcuminoids are an effective and safe therapy to reduce knee pain in adults with knee 
osteoarthritis, without the aforementioned contraindications. All three studies showed a decrease 
in pain from baseline with the use of curcuminoids.  Coincidentally, curcuminoid therapy in 
osteoarthritis decreases the dependence on NSAIDs as adjunctive pain management.  
Although the popularity of researching curcuminoids has continually grown, additional 
studies need to be carried out with larger population sizes and with longer follow up periods to 
see if the treatment effects observed here are carried over on a larger, long-term scale. More 
studies are needed to evaluate the therapeutic index, potential adverse effects, and/or the 
maximal tolerable dose of curcuminoids when treating osteoarthritis.  Furthermore, future studies 
should look to evaluate different dosages of curcuminoids and attempt to establish if there is a 
dose-response pattern.   
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